|
CA2905721A1
|
|
Urethral anastomosis device
|
|
EP2897532A1
|
|
Urethral anastomosis device
|
|
TW201410657A
|
|
Substituted amino-pyrimidine derivatives
|
|
WO2013180866A1
|
|
Catheter valve and methods of using same
|
|
US2013085148A1
|
|
Pyridine derivatives
|
|
CA2850551A1
|
|
Pyridine derivatives
|
|
WO2013049565A1
|
|
Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
|
|
WO2012129234A1
|
|
Urethral anastomosis device and method
|
|
CA2828981A1
|
|
Systems and methods for treating urinary incontinence
|
|
WO2012058671A1
|
|
Substituted quinazoline and pyrido-pyrimidine derivatives
|
|
WO2008144320A2
|
|
Opioid and methods of making and using the same
|
|
US2008226702A1
|
|
Transdermal Delivery Form Disposal Systems and Methods
|
|
AU2007216595A1
|
|
Method for Treating Non-Neuropathic Pain
|
|
US2009124650A1
|
|
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
|
US2008318994A1
|
|
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
|
|
US2008318993A1
|
|
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
|
|
WO2007146005A2
|
|
Sustained release oxycodone composition with acrylic polymer and metal hydroxide
|
|
WO2007146006A2
|
|
Sustained release oxycodone composition with acrylic polymer and a surfactant
|
|
WO2008016413A2
|
|
Dosage limiting medication dispensing method and apparatus
|
|
CA2635603A1
|
|
Treatment of xerostomia
|
